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Abstract. 
 
By pumping calcium from the cytosol to
 
the ER, sarco/endoplasmic reticulum calcium ATPases
(SERCAs) play a major role in the control of calcium
signaling. We describe two SERCA1 splice variants
(S1Ts) characterized by exon 4 and/or exon 11 splicing,
encoding COOH terminally truncated proteins, having
only one of the seven calcium-binding residues, and
thus unable to pump calcium. As shown by semiquanti-
tative RT-PCR, S1T transcripts are differentially ex-
pressed in several adult and fetal human tissues, but not
in skeletal muscle and heart. S1T proteins expression
was detected by Western blot in nontransfected cell
lines. In transiently transfected cells, S1T homodimers
were revealed by Western blot using mildly denatur-
ing conditions. S1T proteins were shown, by confocal
scanning microscopy, to colocalize with endogenous
SERCA2b into the ER membrane. Using ER-targeted
aequorin (erAEQ), we have found that S1T proteins
reduce ER calcium and reverse elevation of ER cal-
cium loading induced by SERCA1 and SERCA2b. Our
results also show that SERCA1 variants increase ER
calcium leakage and are consistent with the hypothesis
of a cation channel formed by S1T homodimers. Finally,
when overexpressed in liver-derived cells, S1T proteins
signiﬁcantly induce apoptosis. These data reveal a fur-
 
ther mechanism modulating Ca
 
2
 
 
 
 accumulation into
the ER of nonmuscle cells and highlight the relevance
of S1T proteins to the control of apoptosis.
Key words: SERCA1 • endoplasmic reticulum • cal-
cium • apoptosis • splice variants
 
Introduction
 
Sarcoplasmic reticulum (SR)
 
1
 
/ER calcium ATPases (SER-
CAs) are calcium pumps that couple ATP hydrolysis with
calcium transport across the SR/ER membrane (MacLen-
nan et al., 1997). As a consequence of this activity, they
maintain a level of resting intra-ER free calcium that is
three to four orders of magnitude higher than the cytosolic
 
Ca
 
2
 
 
 
 concentration. This level is crucial to a variety of ER-
dependent cellular functions, including synthesis, folding
and export of proteins, nucleocytoplasmic transport, stress
response, and the modulation of IP3 (inositol 1,4,5-tri-
phosphate) and SERCA expression (Meldolesi and Poz-
zan, 1998). On the cytosolic side, SERCA proteins control
the frequency of IP3-induced intracellular Ca
 
2
 
 
 
 oscilla-
tions (Camacho and Lechleiter, 1993; Lechleiter et al.,
1998), which in turn have the potential to regulate multiple
cellular processes (Berridge et al., 1998), including gene
expression (Dolmetsch et al., 1997).
SERCAs contain 10 transmembrane domains (M1–
M10), with seven Ca
 
2
 
 
 
-binding residues localized in M4,
M5, M6, and M8 and a large cytosolic domain. This do-
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Abbreviations used in this paper:
 
 aa, amino acid; [Ca
 
2
 
 
 
]
 
c
 
, cytosolic free
calcium concentration; [Ca
 
2
 
 
 
]
 
er
 
, ER intraluminal free calcium concentra-
tion; erAEQ, ER-targeted recombinant aequorin; GFP, green fluorescent
protein; IP3, inositol 1,4,5-triphosphate; NAO, nonyl acridine orange;
 
S1T, SERCA1 splice variant; S1T
 
 
 
4, SERCA1 splice variant lacking
 
exon 11 and 4;
 
 
 
S1T
 
 
 
4, SERCA1 splice variant lacking exon 11; SERCA,
 
SR/ER calcium ATPase; SR, sarcoplasmic reticulum; tBuBHQ, 2,5-
di-(tert-butyl)-1,4-benzohydroquinone. 
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main is made of two parts, one inserted between M2 and
M3, containing the actuator (A) domain involved in the
transduction of conformational changes, and one between
M4 and M5, which contains the nucleotide ATP-binding
(N) domain and the phosphorylation (P) domain. Upon
binding of two Ca
 
2
 
 
 
 by SERCA, Asp-351 undergoes ATP-
dependent phosphorylation followed by a change in the
enzyme conformation and the release of Ca
 
2
 
 
 
 into the ER
lumen (MacLennan et al., 1997; Toyoshima et al., 2000).
SERCAs are encoded by three homologous genes:
SERCA1, SERCA2, and SERCA3 (Wu et al., 1995). Tran-
scripts from these genes undergo alternative splicing in a
developmentally and tissue-specific manner, giving rise to
isoforms that differ in their COOH-terminal region
(MacLennan et al., 1997). SERCA1a (adult form) and 1b
(fetal form) are mainly expressed in fast-twitch skeletal
muscle (Zhang et al., 1995); and SERCA2a, in slow-twitch
skeletal and cardiac muscle, whereas SERCA2b is wide-
spread (Wuytack et al., 1992). SERCA3 is expressed in sev-
eral nonmuscle tissues at variable levels and is always coex-
pressed with SERCA2b (Lytton et al., 1992). SERCA3
transcripts are also spliced, giving rise to three isoforms:
SERCA3a, SERCA3b, and SERCA3c (Martin et al., 2000).
At present, the physiological significance of this hetero-
geneity amongst SERCA isoforms is unclear. However,
recent data from the literature have pointed out their dif-
fering subcellular localizations (Lee et al., 1997) and the
switch from one SERCA isoform to another under condi-
tions that induce the same cell type to differentiate or,
conversely, to proliferate (Launay et al., 1999). As an ex-
ample, isoform switch from the nonmuscle SERCA2b to
muscle SERCA2a was observed during differentiation of
the myoblastic cell line BC
 
3
 
H1 (De Smedt et al., 1991).
Recently, some evidence has emerged to show that
SERCA may also have a direct impact on the processes of
apoptosis, differentiation, and cell proliferation (Ma et al.,
1999; Sakuntabhai et al., 1999; Chami et al., 2000). Accord-
ing to a recent report, SERCA2a overexpression may lead
to apoptosis (Ma et al., 1999). SERCA2b has been shown
to be a stress-inducible protein (Caspersen et al., 2000),
and the stress response is tightly linked to the control of
apoptosis (Jolly and Morimoto, 2000). SERCA2b expres-
sion has also been shown to be modulated by the antiap-
optotic protein Bcl2 (Kuo et al., 1998). Mutations of the
SERCA2 gene have been associated with Darier-White
disease, a dominant inherited dermatosis with abnormal
epidermal cell differentiation and adhesion (Sakuntabhai
et al., 1999). Furthermore, the implication of a SERCA
gene in cell transformation has recently been suggested by
the report of a SERCA1 gene clonal mutation, due to inte-
gration of the Hepatitis B virus genome, occurring in a hu-
man hepatocellular carcinoma but not in the correspond-
ing nontumorous tissue. Viral integration was shown to
cis-activate SERCA1 chimeric transcripts with the splicing
of exon 4 and/or exon 11 (Chami et al., 2000).
To investigate whether exon 4 and/or exon 11 spliced
SERCA1 transcripts are also expressed in normal liver, we
have cloned all SERCA1 transcripts from this tissue. We
show here that exon 4 and/or exon 11 spliced SERCA1
splice variants (S1Ts) are expressed in liver as well as in
several other human adult and fetal tissues. S1T proteins
are expressed and detectable, by Western blot, in non-
 
transfected cell lines derived from human transformed and
primary cells. The splicing of exon 11 creates a frameshift
and a premature stop codon in exon 12. The encoded pro-
teins lack the main part of cytosolic domains N and
 
 
 
P
 
 
 
and
transmembrane segments M5 to M10, which include six of
the seven Ca
 
2
 
 
 
-binding residues, thus avoiding calcium
pumping. The overexpression of S1T proteins induces
apoptosis in three different cell lines. It also reduces the
steady state Ca
 
2
 
 
 
 level in the ER and increases ER Ca
 
2
 
 
 
leakage. In cotransfection experiments, S1T proteins con-
sistently reduce the higher steady state Ca
 
2
 
 
 
 level in the
ER due to SERCA1 or SERCA2b overexpression.
These results provide evidence for a new mechanism
modulating SERCA-dependent Ca
 
2
 
 
 
 accumulation into
the ER, and for implication of S1T proteins in the control
of apoptosis.
 
Materials and Methods
 
cDNA Cloning of S1T
 
Total RNA was extracted from normal liver using TRIzol (Life Technolo-
gies, GIBCO BRL) and quantified by optical density and agarose gel elec-
trophoresis. 3 
 
 
 
g of liver-derived RNA was denatured with 10 U of RN-
asin (RNA guard, Pharmacia Biotech) and 10 pmol of SERCA1 exon 23
antisense primer (5
 
 
 
-gcgtctagacacagctctgcctgaagatgtgtcact-3
 
 
 
) in a 10-
 
 
 
l
volume at 65
 
 
 
C for 5 min. Reverse transcription was performed in a 25-
 
 
 
l
final volume after the addition of 1
 
 
 
 buffer supplied with the enzyme, 0.4
mM of each deoxynucleotide and 20 U of Moloney murine leukemia virus
reverse transcriptase (Life Technologies) at 42
 
 
 
C for 30 min. Amplifica-
tion was performed on one-third of the cDNA by using exon 1 sense (5
 
 
 
-
gcgctcgagatggaggccgctcatgctaaaacac-3
 
 
 
) and exon 23 antisense primers in a
final volume of 50 
 
 
 
l containing 25 mM Tris-Cl (pH 8.9), 40 mM potassium
acetate, 4% glycerol, 200 
 
 
 
M each of dNTP, 1 U Taq polymerase (Life
Technologies), and 0.04 U of Vent exo
 
 
 
 polymerase (New England Bio-
labs, Inc.) in a thermal cycler 480 (PerkinElmer). A hot start technique
was used by adding magnesium chloride after the temperature reached
80
 
 
 
C. The touchdown PCR protocol was applied with denaturation at 94
 
 
 
C
for 30 s, extention step at 70
 
 
 
C for 3 min, annealing temperature starting at
65
 
 
 
C for 30 s, and decreasing by 1
 
 
 
C every two cycles to 55
 
 
 
C, at which
temperature 19 cycles were performed followed by the final step at 72
 
 
 
C
for 10 min. Overall, 40 cycles were carried out. Amplified product was pu-
rified using the Qiaquick spin PCR purification kit (QIAGEN) and cloned
into pcDNA3 vector (Invitrogen). Clones were screened by filter hybrid-
ization with the total SERCA1 probe. Positive clones were picked up in
duplicate and screened using SERCA1 exon 4 and exon 11 specific probes.
SERCA1 positive clones characterized by the splicing of exon 4 and/or of
exon 11 [SERCA1 splice variant lacking exon 11 and 4 (S1T
 
 
 
4), and
SERCA1 splice variant lacking exon 11 (S1T
 
 
 
4)] were then sequenced.
 
Amplification of S1T Variants
 
PCR was performed on normalized cDNAs from different human adult
and fetal tissues (MTC panels human I K1420-1 and human fetal K1425-1;
CLONTECH Laboratories, Inc.). These cDNAs were generated from
poly A
 
 
 
 RNA and normalized to the mRNA expression of six different
housekeeping genes (including glyceraldehyde-3-phosphate dehydroge-
nase and delta lactoferrin) to ensure an accurate assessment of the speci-
ficity and relative abundance of target mRNA. The human MTC panels as
a whole are also normalized against one another, so that the results ob-
tained using human I and human fetal panels could be compared. Hot
start touchdown amplification was then performed as described above,
but with the extension step at 70
 
 
 
C for 1 min. We used primers on
SERCA1 exon 10 (sense primer: 5
 
 
 
-tatcattgacaaggtggatggggacat-3
 
 
 
) and
exon 13 (antisense primer: 5
 
 
 
-cttgacaaacatcttgttgcccacagca-3
 
 
 
). These
primers amplify SERCA1 cDNAs with and without exon 11 splicing.
 
Generation of a Polyclonal Antibody 
Specific to S1T Proteins
 
A peptide corresponding to the 10 COOH-terminal amino acids (aa) of
S1T proteins (RQHSPPWWRR) was synthetized (Sigma-Aldrich), conju- 
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gated to Keyhole limpet hemocyanin and injected i.v. with Freund’s adju-
vant in two New Zealand rabbits. Three immunizations were performed,
and sera were collected at different times and purified by affinity chroma-
tography against the peptide.
 
Cell Lines
 
We used HuH7 cells, derived from human hepatocellular carcinoma,
CCL13 cells (American Type Culture Collection) derived from liver tu-
mor cells, HeLa cells (CCL-2; American Type Culture Collection) derived
from human cervix epithelioid carcinoma, T-47D cells (HTB 133; Ameri-
can Type Culture Collection) derived from human infiltrating breast duc-
tal carcinoma, LNCaP cells (CRL 1740; American Type Culture Collec-
tion) derived from human metastatic prostatic adenocarcinoma, and Hs27
(CRL 1634; American Type Culture Collection) derived from human
newborn foreskin primary fibroblasts.
 
Isolation of Microsomal Fraction and Immunoblotting
 
Liver microsomes were isolated as described (Maruyama and MacLen-
nan, 1988). Proteins were treated with concentrated urea (20 mg/50 
 
 
 
g
protein), 1.8% SDS, and 9% 
 
 
 
-mercaptoethanol and heated at 100
 
 
 
C for 1
min. After SDS-PAGE (10%), proteins were electrotransferred onto
PVDF membranes Immobilon™-P (Millipore). For immunodetection, we
used guinea pig polyclonal antibody 79B (diluted 1:5,000) raised against
rabbit fast-twitch skeletal muscle SERCA1 (gift from A. M. Lompré, The
French Institute of Health and Medical Research, INSERM, Chatenay-
Malabry, Ferance) and anti-S1T (diluted 1:1,000) according to a reported
protocol (Fuentes et al., 2000). After 1 h contact with the secondary anti-
body, the signal was revealed with the SuperSignal West Pico solution
chemiluminescent substrate (Pierce Chemical Co.). Dimers or aggregates
were sought by 7% SDS-PAGE in heated samples without urea (Soulié et
al., 1996). For the antibody neutralization test, after hybridization with the
79B antibody, we applied the Restore™ Western Blot Stripping buffer
(Pierce Chemical Co.) for 10 min at room temperature. Next, we per-
formed three washes for 10 min at room temperature with the TBS-Tween
solution (10 mM Tris HCl, pH 7.5, 100 mM NaCl, 0.2% Tween 20 [Sigma-
Aldrich]) and left the membrane overnight in the TBS-Tween–milk (5%
milk). The next day, we mixed 20 
 
 
 
g of 79B antibody and 200 
 
 
 
g the SR
antigen (sarco-endoplasmic reticulum from rabbit) in a TBS–milk solution
and allowed it to be in contact overnight on a wheel device. This 1 ml mix
was then added to 9 ml of TBS-Tween–milk solution and was used to hy-
bridize the membrane for 1 h at room temperature.
 
Cloning and Transient Transfection Analyses
 
S1T
 
 
 
4, S1T
 
 
 
4, and SERCA1 were cloned into pcDNA3.1 (Invitrogen),
subcloned into the green fluorescent protein (GFP) fusion construct
pEGFP-N1 (CLONTECH Laboratories, Inc.) vector and pcDNA3.1/
Myc-His (Invitrogen) and used to transiently transfect cell lines (HuH7,
CCL13, HepG2, COS7, and HeLa cells) using ExGen solution (Eurome-
dex). We used pig SERCA2b cDNA cloned in PsG5 vector (Stratagene)
(Brini et al., 2000). The expression of all our constructs was driven by the
CMV promoter, except the pig SERCA2b cDNA (SV-40 promoter). For
transient transfection, 3 
 
  
 
10
 
5
 
 cells were seeded in six-well plates. The
next day, transfection was carried out with 0.2 
 
 
 
g pEGFP-N1 (GFP empty
vector to test the transfection efficiency) and 1.8 
 
 
 
g of the construct of in-
terest by using the ExGen product and the supplied protocol. Experi-
ments for immunolabeling and with ER-targeted recombinant aequorin
(erAEQ) cotransfection were performed on 13-mm glass coverslips. For
aequorin measurements, we cotransfected 0.5 
 
 
 
g erAEQ plus 1.5 
 
 
 
g of
the construct of interest (or 0.7 
 
 
 
g of each in the case of two constructs).
Cells were washed three times in PBS buffer 20 h after transfection and
analyzed 48 or 72 h after transfection.
 
Immunohistochemistry
 
Transfected HuH7 cells were fixed in 4% paraformaldehyde and perme-
abilized with 0.2% Triton X-100 for 10 min. Anti-S1T antibody, diluted
1:25, was first saturated with 4.8 
 
  
 
10
 
6
 
 nontransfected HuH7 cells in
0.05% Tween and 1% BSA in 300 
 
 
 
l final volume for 2 h at 4
 
 
 
C. After
centrifugation at 5,000 rpm for 5 min, the supernatant was collected. Non-
specific binding sites were blocked with 3% BSA for 1 h. Anti-S1T anti-
body was then used at 1:50 dilution in 3% BSA. Immunodetection was
carried out using the Envision Plus system (Dako).
 
Immunofluorescence and Confocal Microscopy Analysis
 
Transfected cells were fixed in 4% paraformaldehyde and permeabilized at
4
 
 
 
C for 10 min in cold methanol (
 
 
 
20
 
 
 
C). Nonspecific binding sites were
blocked with 3% BSA. Immunostaining was performed with anti-SERCA2
monoclonal antibody (clone IID8; Novocastra Ltd.), diluted 1:200, or anti-
mitochondria polyclonal antibody (gift from C. Marsac, Neckler Faculty of
Medicine, Paris, France), diluted 1:200. Immunodetection was carried out
using Cyanin5-conjugated secondary antibody diluted 1:200. Coverslips
were analyzed using confocal laser scanning microscopy (LSM 510; ZEISS).
 
Apoptosis
 
Apoptosis was assessed using two complementary approaches. Cells were
analyzed 72 h after transfection with GFP fusion constructs. The percent-
age of apoptotic nuclei was counted in 
 
 
 
600 transfected GFP-positive
cells in at least three independent experiments using DNA-dye 7-amino
actinomycin D (Sigma-Aldrich) nuclear staining. In parallel, a FACScan
 
®
 
flow cytometer was used to record the combination of alterations to the
mitochondrial structure, assessed by nonyl acridine orange (NAO) incor-
poration (Petit et al., 1995) and cell size (Forward Scatter: FSC). After
transfection with the pcDNA3 clones, adherent and floating cells were in-
cubated for 30 min at 37
 
 
 
C in PBS containing 4 
 
 
 
M NAO before analysis.
Data from 2 
 
  
 
10
 
4
 
 events were recorded on a logarithmic scale and ana-
lyzed using CellQuest software.
 
Aequorin Measurements
 
The aequorin chimera targeted to the ER (erAEQ) (Montero et al.,
1995) was transfected alone (control) or cotransfected with SERCA1,
SERCA2b and/or S1T constructs in HuH7, CCL13, or HeLa cells. Ae-
quorin measurements were performed as described (Pinton et al., 2000),
48 h after transfection in HeLa cells and 48 and 72 h after transfection in
HuH7 and CCL13 cells. To achieve high efficiency reconstitution of the
erAEQ, luminal ER free calcium concentration ([Ca
 
2
 
 
 
]
 
er
 
) must first be re-
duced. This was obtained by incubating the cells for 1 h at 4
 
 
 
C in Krebs-
Ringer modified buffer (KRB; 125 mM NaCl, 5 mM KCl, 1 mM Na
 
3
 
PO
 
4
 
, 1
mM MgSO
 
4
 
, 5.5 mM glucose, and 20 mM Hepes, pH 7.4, at 37
 
 
 
C) supple-
mented with 5 
 
 
 
M n-coelenterazine, 5 
 
 
 
M of the Ca
 
2
 
 
 
 ionophore ionomy-
cin, and 600 
 
 
 
M EGTA. After incubation, the cells were extensively
washed with KRB supplemented with 2% BSA and 1 mM EGTA and
then with 100 
 
 
 
M EGTA for 30 s. The coverslips were then transferred to
the luminometer and perfused in KRB supplemented with 1 mM CaCl
 
2
 
solution until the plateau level was reached (refilling phase). To obtain
lower [Ca
 
2
 
 
 
]
 
er
 
 values in control cells, cells were perfused with KRB sup-
plemented with 600, 300, or 100 
 
 
 
M CaCl
 
2 
 
solution.
To analyze the Ca
 
2
 
 
 
 leak rate from the ER, after reaching the plateau
level, Ca
 
2
 
 
 
 release was initiated by treating the cells with 50 
 
 
 
M 2,5-
di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ) (SERCA pump in-
hibitor). The maximum rates of Ca
 
2
 
 
 
 release (measured from the first
derivative) at different [Ca
 
2
 
 
 
]
 
er
 
 values were calculated and plotted for
S1T-transfected and control cells.
All aequorin measurements were carried out in KRB and terminated
by lysing the cells with 100 
 
 
 
M digitonin in a hypotonic Ca
 
2
 
 
 
-rich solution
(10 mM CaCl
 
2 
 
in H
 
2
 
O), thus discharging the remaining aequorin pool. The
light signal was collected and calibrated into [Ca
 
2
 
 
 
]
 
 
 
values as previously
described (Brini et al., 1995; Rizzuto et al., 1995). In brief, a 13-mm round
coverslip with the transfected cells was placed in a perfused thermostated
chamber located in close proximity to a low-noise photomultiplier, with
built-in amplifier discriminator. The output of the discriminator was cap-
tured by a Thorn-EMI photon counting board and stored in an IBM-com-
patible computer for further analyses. Aequorin luminescence data were
calibrated off-line into [Ca2 ] values using a computer algorithm based on
the Ca2  response curve of mutated-type aequorin, as previously de-
scribed (Montero et al., 1995).
Statistical Methods
Continuous variables were compared using Student’s t test or a nonparamet-
ric (Mann-Whitney) test when their distribution was skewed. Categorical
variables were compared using the Chi square test with Yates correction.
Online Supplementary Material
Online supplementary Tables SI and SII show comparative analysis of
Ca2  leak in HeLa (Table SI) and HuH7 (Table SII) cells transfected withThe Journal of Cell Biology, Volume 153, 2001 1304
S1T constructs (S1T 4 and S1T 4) and in the corresponding nontrans-
fected cells (NTC). Comparison of Ca2  leak values were only made be-
tween experiments having comparable levels of [Ca2 ]er (not exceeding 50
 M). This analysis revealed that the leak value is higher in S1T 4- and
S1T 4-transfected cells than in nontransfected cells.
Online supplementary Figure A shows curves corresponding to se-
lected leak values in Table SII (see codes under curves and in Table SII).
These curves show also that the passive leak obtained after addition of
tBuBHQ is higher in S1T 4- and S1T 4-transfected cells than in non-
transfected cells (control).
Online supplementary Figure B shows the indication of the time inter-
val needed to obtain a decrease of [Ca2 ]er from 120 to 57  M in the pro-
files depicted in C of Fig. 7. This time interval is 165 s in nontransfected
cells (control) and 28 and 37 s in S1T 4- and S1T 4-transfected cells, re-
spectively. Supplementary material is available at http://www.jcb.org/cgi/
content/full/153/6/1301/DC1.
Results
Cloning of Spliced SERCA1 Variants
We cloned SERCA1 transcripts from normal liver and ob-
tained 25 clones. Upon analysis with full-length SERCA1,
SERCA1 exon 11, and SERCA1 exon 4 specific probes, 17
clones corresponded to SERCA1 and 8 clones were found
to be characterized by exon 11 splicing (S1T 4), including
two that also exhibited exon 4 splicing (S1T 4). This re-
sult was confirmed by sequence analysis. Exon 11 splicing
leads to a frameshift encoding 22 aa (PKVSMRRSARP-
PRQHSPPWWRR) followed by a premature stop codon
in exon 12 (Fig. 1 A).
Predicted Structure of S1T Proteins
According to the recently reported crystal structure of rab-
bit SERCA1a resolved at 2.6 Å (Toyoshima et al., 2000),
the calcium-transporting ATPase (Fig. 1 B, left) is pro-
vided with two calcium-binding sites formed by the side-
chain oxygen atoms of seven transmembrane residues and
by the backbone oxygen atoms of three transmembrane
residues (Toyoshima et al., 2000; Zhang et al., 2000). Cal-
cium-binding site I is formed by side-chain oxygen atoms
of Asn-768 (M5), Glu-771 (M5), Thr-799 (M6), Glu-908
(M8) (Fig. 1 B,  ) and of Asp-800 (M6), which also partic-
ipates in calcium-binding site II (Fig. 1 B,  ). Calcium-
binding site II is formed by side-chain oxygen atoms of
Asn-796 (M6), Glu-309 (M4) ( ), and Asp-800, and by the
backbone oxygen atoms of Val-304 (M4), Ala-305 (M4),
and Ile-307 (M4) ( ). In addition to that, calcium-binding
is also controlled by L6/7 cytoplasmic loop in which three
residues, Asp-813, Asp-815, and Asp-818 ( ), play a criti-
cal role (Falson et al., 1997; Menguy et al., 1998).
The structural consequence of splicing of exon 11 in
S1T 4 and S1T 4 is the deletion of transmembrane seg-
ments M5 to M10 (Fig. 1 B, middle and right). Thus, S1T
proteins keep four of the six calcium-binding residues of
calcium-binding site II, including Val-304, Ala-305, and
Ile-307. These three residues participate in calcium bind-
ing by their backbone oxygen atom depending on their po-
sition in the whole protein three-dimensional structure,
thus in S1T proteins their contribution to calcium binding
could be compromised. In contrast, the fourth residue,
Glu-309, is still able to interact with calcium by its side-
chain oxygen atom. Moreover, in the new structural con-
formation of S1T, acidic or polar residues, in particular
Glu-58 (M1), and probably also Gln-108 (M2), at least in
Figure 1. SERCA1 cDNA clones isolated from normal liver and
the predicted structure of encoded proteins. (A) cDNA structure
of the SERCA1 adult isoform with a stop codon in exon 22
(SERCA1a) and of the neonatal isoform characterized by exon
22 splicing and a stop codon in exon 23 (SERCA1b). Spliced iso-
forms (S1T 4 and S1T 4) are characterized by exon 4 and/or
exon 11 splicing. Exon 11 splicing leads to a frameshift, encoding
a 22-aa peptide ( ), and a premature stop codon in exon 12. (B)
Predicted topological structure of S1T proteins as compared with
SERCA1. (Left) SERCA1. Numbers below drawings indicate
transmembrane domains (M). Phosphorylatable Asp-351 is indi-
cated.   and   indicate transmembrane residues involved in cal-
cium-binding sites I and II, respectively, and that bind calcium by
a side-chain oxygen atom.   corresponds to the Asp-800 residue
that participates in both sites I and II.   correspond to residues
involved in calcium-binding site II and that bind calcium by the
backbone oxygen atom.   indicate cytoplasmic calcium-binding
residues. (Middle and right) S1T proteins. The 22-aa COOH-ter-
minal peptide is depicted as a dotted line, and the peptide (35 aa)
encoded by exon 4 and deleted in S1T 4 is in gray (right). (C)
Three-dimensional structure of rabbit SERCA1a, according to
Toyoshima et al. (2000), using Rasmol 2.7.1 and the 1EUL PDB
file (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId 1EUL, see
supplementary materials for directions on viewing under differ-
ent orientations). The A transduction (A), phosphorylation (P),
and nucleotide-binding (N) domains are indicated. Secondary
structures are displayed in ribbons. Those that are common to
SERCA1 and S1T proteins are in color:  -sheets are in dark yel-Chami et al. SERCA1 Truncated Proteins Reduce ER Calcium 1305
S1T 4, could help to create a new calcium-binding site
(Fig. 1 D). Domains P and N are nearly completely re-
moved in S1T proteins (Fig. 1, C and D), suggesting that
they are neither able to bind ATP nor to transfer a phos-
phate on Asp-351, the residue that is reversibly phosphor-
ylated during calcium transport. The frameshift created by
splicing of exon 11 gives rise to 22 COOH-terminal mu-
tated residues, depicted as an hypothetical structure (dot-
ted line) in Fig. 1, B and D.
S1T 4 also lacks a peptide (74-VLAWFEEGEETIT-
AFVEPFVILLILIANAIVGVWQ-108), depicted in blue
in Fig. 1, C and D, corresponding to the last five COOH-
terminal residues of M1, the connecting loop L1/2, and the
main part of M2. As a consequence, residues Phe-73 and
Glu-109 come in close contact (Fig. 1 B, right, C and D).
This deletion is expected to deeply modify the remaining
membrane domain of the protein. Its three-dimensional
structure is, at present, unpredictable.
Therefore, according to their predicted structure and by
analogy with previously reported SERCA1 mutants (Mac-
Lennan et al., 1998), S1T 4 and S1T 4 proteins, which
expected size is 46 and 43 kD, respectively, cannot func-
tion as calcium pumps.
Spliced SERCA1 Variants Are Expressed 
in Human Adult and Fetal Tissues
RT-PCR analysis of SERCA1 spliced transcripts was per-
formed on different human adult and fetal tissues. We
used a set of primers (see Materials and Methods) that co-
amplify SERCA1 cDNAs with or without exon 11 splicing
(Fig. 2; SERCA1 and S1T). S1T are expressed in different
human adult (pancreas, liver, kidney, lung, and placenta)
and fetal (kidney, liver, brain, and thymus) tissues and are
not expressed in adult skeletal muscle, heart, and brain
and fetal skeletal muscle and heart (Fig. 2). The relative
amount of S1T as compared with SERCA1 differed ac-
cording to the tissue analyzed, and was higher in fetal
liver, kidney, and brain than in the corresponding adult tis-
sues. Although adult brain only expressed SERCA1, only
S1T transcripts were detectable in the corresponding fetal
tissue. These observations are consistent with a switch of
SERCA1 to S1T expression in fetal cells. Our assessment
is reliable for the following reasons: (a) RT-PCR results
were reproducibly obtained on cDNAs normalized using
the expression of several housekeeping genes (see Materi-
als and Methods); (b) the relative amount of SERCA1 and
S1T was estimated by using the same primer set which am-
plifies both cDNAs; and (c) the PCR product was ob-
tained at the exponential PCR phase and semiquantified
by image analysis (NIH program).
Thus, the variable expression pattern of S1T variants
that we observed rules out their illegitimate transcription
(Chelly et al., 1989) and is consistent with a biological
function of the corresponding proteins.
S1T Proteins Are Expressed in Different Human-derived 
Cell Lines and Localize to the ER Membrane
We used a polyclonal antibody (anti-S1T) selectively di-
rected to the COOH-terminal 10 aa created by exon 11
splicing. Western blot analysis of microsomal fraction from
cells transiently transfected with SERCA1 and S1T 4 al-
lowed us to detect both SERCA1 and S1T 4 proteins us-
ing the 79B antibody, directed to the first cytoplasmic loop
of SERCA1, and only the S1T 4 band using the anti-S1T
antibody. S1T 4 was detected as a monomer (46 kD) in
denaturing conditions (heated sample treated with urea)
(Soulié et al., 1996) (Fig. 3 A). In the microsomal cellular
fraction obtained from nontransfected CCL13, T-47D, and
Hs27 cell lines, we found a clear 46-kD band using the anti-
S1T antibody (Fig. 3 B) corresponding to the S1T 4 iso-
form. In fact, cloning analyses had shown that expression
of the S1T 4 isoform is lower than that of the S1T 4 iso-
form. No bands were observed in microsomal samples
from HeLa and LNCaP cell lines. The specificity of this
finding was assessed by the neutralization assay shown in
Fig. 3 C. By using the anti-SERCA 1 antibody 79B, we re-
low, and cytosolic   helices are in magenta. Residues from Leu-
396 to Gly-994 (COOH-terminal) removed by the splicing of
exon 11 in S1T are in gray. Transmembrane   helices M1, M2,
M3, and M4 are depicted in yellow, green, violet, and red, respec-
tively. The peptide Val-74 to Gln-108 encoded by exon 4 and de-
leted in the S1T 4 protein is indicated in blue. Residues Phe-73
and Glu-109, which come in contact in S1T 4, are indicated.
Phosphorylatable Asp-351 and calcium-binding residue Glu-309
are also shown. Calcium ions are space filled and colored in cyan.
(D) Hypothetical three-dimensional structure of S1T deduced
from that of rabbit SERCA1a. Residue Val-395 in S1T is fol-
lowed by a 22-aa COOH-terminal peptide generated by the
frameshift and depicted as a dotted line. Its structure is unknown.
The region colored in blue is removed in the S1T 4 protein and
presumably leads to an important structural rearrangement. The
position of the calcium atom located near residue Glu-309 is hy-
pothetical. Residues Glu-58 and Gln-108, which are close to Glu-
309 and may participate in the channelling of calcium in S1T 4
dimers along the side of transmembrane domains M2–M4, are
displayed in wireframe.
Figure 2.  Amplification of native S1T transcripts of human
adult and fetal tissues. Semiquantitative PCR analysis of S1T tis-
sue expression patterns was performed with Marathon-ready
cDNA (CLONTECH Laboratories, Inc.) using primers on
SERCA1 exons 10 and 13. This set of primers amplifies SERCA1
transcripts with (447 bp; SERCA1) and without (344 bp; S1T)
exon 11 splicing. S1T corresponds to the exon 11–spliced isoforms
with or without exon 4 splicing (S1T 4 and S1T 4). Semiquanti-
fication was performed using the NIH image v1.62 program.
Numbers below each lane indicate the proportion (%) of
SERCA1 and S1T transcripts in each tissue.The Journal of Cell Biology, Volume 153, 2001 1306
vealed the S1T band (46 kD) in the T-47D nontransfected
cell line and the HuH7 cell line transfected with the S1T 4
construct (S1T 4) as well as the SERCA1 band (110 kD)
in the T-47D cell line and in the reference SR sample (Fig.
3 C, left). After dehybridization of the membrane and
rehybridization with the 79B antibody, after its adsorp-
tion  with SR antigen (see Materials and Methods), the
SERCA1 and S1T bands in T-47D and transfected HuH7
cells disappeared, as well as the bands corresponding to 3
and 10 ng of SR (Fig. 3 C, right). This result shows the
specificity of S1T protein detection in transfected and non-
transfected cell lines. This test also led us to observe that,
in the T-47D cell line (Fig. 3 C, left), the amount of ex-
pressed SERCA1 and S1T isoforms is similar.
The ER localization of S1T was assessed using two com-
plementary approaches: immunolabeling and scanning
confocal microscopy analysis. Immunohistochemistry and
immunofluorescence performed on S1T 4-transfected
cells with anti-S1T antibody showed a reticular signal con-
sistent with S1T 4 localization to the ER (Fig. 3 D). Simi-
lar results were obtained using cells transfected with
S1T 4 and S1T 4 fused to the myc tag and immunofluo-
rescence using anti-myc antibody (data not shown).
To confirm this observation, we used scanning confocal
microscopy analysis of HuH7 cells transfected with the
SERCA1–GFP- and S1T 4–GFP-expressing vectors. En-
dogenous SERCA2b expression was revealed by the anti-
SERCA2 monoclonal antibody and provided evidence for
the expected colocalization of SERCA1 and SERCA2
proteins (Fig. 4 A). In contrast, SERCA1 was not found to
colocalize with the mitochondrial reticulum (Fig. 4 C),
which has been reported to be in close contact with the ER
(Rizzuto et al., 1998). Our results also showed that S1T 4
colocalizes with SERCA2b (Fig. 4 B) but not with mito-
chondria (Fig. 4 D). This study made two important find-
ings: (1) that S1T proteins are localized to the ER mem-
brane and (2) that their localization may favor their
interaction with the endogenous SERCA2b calcium pump.
S1T Proteins Reduce the Steady 
State Level of ER Calcium
Since S1T proteins are localized to the ER membrane, we
investigated whether they could modify the ER Ca2 
content ([Ca2 ]er) despite the fact that they are unable
to pump calcium. To this aim, we used the erAEQ as a
calcium probe. Cotransfection of erAEQ cDNA– and
cDNA-encoding S1T 4 or S1T 4 was performed in
HuH7, CCL13, and HeLa cells. To obtain a quantitative
estimation of [Ca2 ]er values, the ER Ca2  concentration
was reduced during the phase of erAEQ reconstitution
with coelenterazine and the subsequent initial phase of
perfusion (see Materials and Methods). Under these con-
ditions, [Ca2 ]er was  10  M. When calcium in the perfu-
sion medium was switched to 1 mM, [Ca2 ]er level rose
gradually to reach a plateau value (steady state level). In
HuH7 cells cotransfected with erAEQ and S1T 4 or
S1T 4, the plateau value was significantly lower 72 h after
transfection (174   58  M, n   10, p-value   0.01, and 241  
78  M, n   8, p-value   0.05, respectively) than that seen
in control cells only transfected with erAEQ (330   72
 M, n   14) (Fig. 5 A and Table I). Taking the [Ca2 ]er of
Figure 3.  Detection of
S1T 4 protein in transiently
transfected HuH7 cells and
nontransfected cell lines. (A)
The same Western blot was
successively hybridized with
anti-SERCA1 antibody (79B)
directed to the first cytoplas-
mic loop of SERCA1 and
therefore recognizing both
SERCA1 (110 kD) and
S1T 4 (46 kD) proteins and
with anti-S1T antibody di-
rected to the S1T COOH-ter-
minal 10 aa, which recognizes
only S1T proteins. NTC,
HuH7 nontransfected cells
used as negative control. (B)
Detection by Western blot
analysis and anti-S1T anti-
body of S1T protein in HuH7
cells transiently transfected
with S1T 4 (S1T 4), and in
human nontransfected cell
lines CCL13, T-47D, and
Hs27, but not in HeLa and
LNCaP. (C) Neutralization assay. (left) The microsomal fraction of the nontransfected T-47D cell line and of the HuH7 cell line trans-
fected with the S1T 4 construct (S1T 4) was analyzed by Western blot using the anti-SERCA1 antibody 79B. SR (1, 3 ng; 2, 10 ng; and
3, 30 ng), purified sarcoplasmic reticulum from rabbit used as reference sample. (right) The membrane was dehybridized and rehybrid-
ized with the 79B antibody after its adsorption with the SR antigen (see Materials and Methods). Note the disappearing of SERCA1
and S1T bands in T-47D and in transfected HuH7 cells, and of the bands corresponding to 3 ng and 10 ng of SR. (D) A1T 4 transiently
transfected HuII7 cells were analyzed by immunohistochemistry using anti-S1T antibody. Arrows indicate transfected cells.Chami et al. SERCA1 Truncated Proteins Reduce ER Calcium 1307
control cells as 100%, the ER calcium steady state level
was reduced to 53% in S1T 4 and to 73% in S1T 4 trans-
fected cells. This effect was also found 48 h after transfec-
tion with the S1T 4 construct, the plateau value being re-
duced to 56% in transfected cells (n   11, p-value   0.01)
as compared with control cells (n   10).
In HeLa cells cotransfected with erAEQ and S1T 4 or
S1T 4, the plateau value was also significantly lower
(269   33  M, n   14; p-value   0.01, and 287   44  M,
n   9, p-value   0.01, respectively) than that seen in con-
trol cells (400   48  M, n   7) (Fig. 5 B and Table II) 48 h
after transfection. In fact, taking the [Ca2 ]er of control
cells as 100%, the ER calcium steady state level was re-
duced to 67% in S1T 4 and 72% in S1T 4-transfected
cells. Similar results were obtained with CCl13 cells (data
not shown). These results demonstrate that S1T proteins
reduce [Ca2 ]er levels in three different cell lines.
S1T Proteins Reverse SERCA1 and SERCA2b-related 
Increase in the ER Calcium Content
To investigate the effect of S1T in a context of increased
ER calcium pumping, we overexpressed SERCA1, or the
ubiquitous SERCA2b, in HuH7 and HeLa cells. HuH7
cells overexpressing SERCA1 or SERCA2b proteins
showed a significantly higher steady state ER calcium
level than controls (448   81  M, n   13, p-value   0.01,
and 687   105  M, n   6, p-value   0.01, respectively, vs.
330   72  M, n   14) (Fig. 6, A and B, and Table I).
Cotransfection of SERCA1 and S1T 4 or S1T 4 signifi-
cantly reduced [Ca2 ]er to 297   78  M, n   11, p-value  
0.01, and 343   99  M, n   10, p-value   0.02), respec-
tively (Table I). Cotransfection of SERCA2b and S1T 4
or S1T 4 also significantly reduced [Ca2 ]er to 434   131
 M, n   4, p-value   0.01, and 445   61  M, n   4,
p-value   0.01, respectively (Table I). Similar results were
obtained in HeLa cells transfected with SERCA1 (446  
59  M, n   8) and SERCA1 S1T 4 (329   55  M, n  
4, p-value   0.05) or SERCA1 S1T 4 (327   59  M,
n   4, p-value   0.05) (Fig. 6 C and Table II).
In our system, SERCA2b induced a higher steady state
ER calcium level than SERCA1. This result may be due to
Figure 4.  S1T 4 protein colocalizes with SERCA2b in the ER
membrane. HuH7 cells transiently transfected with GFP fusion
constructs, SERCA1–GFP (A 1 and C 1) or S1T 4–GFP (B 1
and D 1), were immunolabeled with anti-SERCA2 monoclonal
antibody (clone IID8) (A 2 and B 2) or with antimitochondria E2
protein polyclonal antibody (anti-mito) (C 2 and D 2) and cyanin
5–coupled secondary antibody. Merging of the two signals (A 3,
B 3, C 3, and D 3) and the cytofluorograms (obtained by plotting
each green fluorescence point of the cell on the x axis and each
red fluorescence point on the y axis) demonstrate the colocaliza-
tion of SERCA1 and S1T 4 with endogenous SERCA2b (A 4
and B 4) in the ER membrane, but not with mitochondria (C 4
and D 4). Colocalization is indicated by the white points (A 5 and
B 5) corresponding to the cytofluorogram white area with stron-
gest colocalizing green and red fluorescence (A 6 and B 6).
Figure 5.  S1T proteins reduce the ER calcium content. [Ca2 ]er
measurements were performed in HuH7 cells (A) and in HeLa cells
(B) transfected with erAEQ (control), cotransfected with erAEQ
and S1T 4 (S1T 4), or cotransfected with erAEQ and S1T 4
(S1T 4). Parallel batches of HeLa or HuH7 cells were analyzed 48
and 72 h after transfection, respectively. To obtain a quantitative es-
timation of [Ca2 ]er, [Ca2 ] was reduced during reconstitution of the
aequorin with n-coelenterazine and the subsequent initial phase of
perfusion. Where indicated, cells were perfused with 1 mM CaCl2
solution (CaCl2) until the plateau level was reached. Aequorin
lumeniscence was collected and calibrated into [Ca2 ] values.The Journal of Cell Biology, Volume 153, 2001 1308
the different type (pig versus human) of ATPase used and/
or to the type of promoter (SV-40 versus CMV).
Endogenous SERCA2b Expression Is Not 
Modified by the Overexpression of S1T
Although S1T are unable to pump calcium, they could, in
theory, downregulate the endogenous SERCA2b expres-
sion, thus reducing ER calcium loading. To address this
question, COS cells were transfected with S1T 4-express-
ing vector, and Western blot analysis was carried out on the
microsomal fraction of S1T 4 transiently transfected cells
and nontransfected cells. The expression of endogenous
SERCA2b was detected using the anti-SERCA2 mono-
clonal antibody. Although  60% of COS cells expressed
S1T 4 (assessed by cotransfection with GFP empty vec-
tor), no major differences in SERCA2b expression were
observed repeatedly in transfected as compared with non-
transfected cells (Fig. 7 A). Consistent results were ob-
tained with HuH7 cells, in which transfection efficiency
was lower ( 40%). Thus, the reduced ER calcium loading
due to overexpression of S1T is not related to a sound
downregulation of endogenous SERCA2b expression.
S1T Proteins Increase Calcium Leakage from the ER
An alternative mechanism leading to reduced [Ca2 ]er in
S1T-overexpressing cells may be an increased rate of cal-
cium leakage from the ER. It is well established that the
rates of calcium uptake and release are equal in the steady
state. Thus, the rate of [Ca2 ]er decrease upon the block-
ade of SERCA should reflect the rate of Ca2  cycling
across the ER membrane and the leakage rate at any given
steady state [Ca2 ]er (Pinton et al., 2000). Fig. 7 B shows
the relationship between the [Ca2 ]er value and the leak-
age rate, which could be fitted using a power equation.
There is a clear profile of faster Ca2  efflux in S1T 4- and
S1T 4-overexpressing HuH7 cells than in control cells,
for the majority of [Ca2 ]er values. Fig. 7 C shows three
overlapping curves obtained from HuH7 cells nontrans-
fected (control) and transfected with the S1T 4 or S1T 4
construct, having comparable steady state calcium levels.
The kinetics of Ca2  efflux is clearly more rapid in S1T-
transfected than in nontransfected cells. Consistent results
were obtained in S1T 4- and S1T 4-overexpressing
HeLa cells (data not shown).
S1T Proteins Are Expressed as Dimers
The question has been raised as to the mechanism through
which S1T overexpression increases ER Ca2  leakage.
Two possibilities were considered: (1) that the direct bind-
ing of S1T to endogenous SERCA would partially block
Table I. Analysis of Steady State [Ca2 ] Levels in the ER of 
Transiently Transfected HuH7 Cells
Constructs ER [Ca2+]   SEM p-value n % ER [Ca2+]*
µM
Control 330   72 14 100
S1T 4 174   58  0.01‡ 10 53
S1T 4 241   78  0.05‡ 87 3
SERCA1 448   81  0.01‡ 13 136
SERCA1   S1T 4 297   78  0.01§ 11 90
SERCA1   S1T 4 343   99 0.02§ 10 103
SERCA2 678   105  0.01‡ 6 208
SERCA2   S1T 4 434   131  0.01  4 131
SERCA2   S1T 4 445   61  0.01  4 134
Mean   SEM. n, total number of erAEQ measurement tests.
*Evaluation of ER Ca2  loading as compared to that of nontransfected cells, consid-
ered as reference (100%).
‡Versus control.
§Versus SERCA1.
 Versus SERCA2.
Table II. Analysis of Steady State [Ca2 ] Levels in the ER of 
Transiently Transfected HeLa Cells
Constructs ER [Ca2+]   SEM p-value n % ER [Ca2+]*
µM
Control 400   48 7 100
S1T 4 269   33  0.01‡ 14 67
S1T 4 287   44  0.05‡ 97 2
SERCA1 446   59 NS‡ 8 112
SERCA1  S1T 4 329   55  0.05§ 48 2
SERCA1   S1T 4 327   59  0.05§ 48 2
Mean   SEM. n, total number of erAEQ measurement tests.
*Evaluation of ER Ca2  loading as compared to that of nontransfected cells, consid-
ered as reference (100%).
‡Versus control.
§Versus SERCA1.
Figure 6.  S1T proteins reverse SERCA1- and SERCA2b-
induced increases of [Ca2 ]er. HuH7 (A and B) and HeLa (C)
cells were cotransfected with erAEQ and SERCA1 (A and C) or
SERCA2b (B). Cotransfection of erAEQ, SERCA1, or
SERCA2b and S1T constructs was carried out as described in
Materials and Methods. Quantitative assessment of [Ca2 ]er was
performed as described in the legend to Fig. 5.Chami et al. SERCA1 Truncated Proteins Reduce ER Calcium 1309
ATPase activity, thus enhancing ER Ca2  leakage; and (2)
that the faster rate of Ca2  efflux from the ER is due to a
cation channel formed by S1T dimers or aggregates. To in-
vestigate these two possibilities, we performed a Western
blot analysis under mild denaturing conditions (heated
sample without urea) (Soulié et al., 1996). Under these
conditions, a relevant proportion of S1T 4 was found to
form homodimers (92 kD) (Fig. 7 D). By comparison, a far
smaller proportion of SERCA2b was shown to form ho-
modimers. We also noticed that, during repeated analyses,
no heterodimers formed by SERCA2b and S1T 4 (ex-
pected size 151 kD) could be detected (Fig. 7 D, right). Al-
though we cannot exclude S1T aggregates and/or multi-
dimers in native conditions, they are not visible using mild
denaturing conditions. This finding indicates that, if S1T
aggregates and/or multidimers exist under native condi-
tions, their stability is lower than that of homodimers. In
this setting, the existence of multihomodimers in native
conditions would be more plausible than that of S1T ag-
gregates. Thus, the simplest explanation for the increase in
ER Ca2  leakage is the formation of a cation channel, in
the ER membrane, by the dimerization of S1T proteins.
Indeed, each S1T monomer has a calcium-binding residue
(Glu-309), which, along with additional residues, in partic-
ular Glu-58 and Gln-108, could participate to create a cal-
cium-binding site in the new protein conformation, and a
cation channel in the case of S1T dimerization.
Overexpression of S1T Proteins Induces Apoptosis
In a previous report, we showed that the overexpression of
Hepatitis B virus–SERCA1 chimeric transcripts (with
exon 4 and/or exon 11 splicing) induces apoptosis and that
this effect is due to both the viral and SERCA moieties of
chimeric proteins (Chami et al., 2000). Along the same
line, we investigated whether S1T overexpression could be
associated with apoptotic cell death. Apoptosis was as-
sessed using two complementary approaches. Morphologi-
cal analysis was based on counting of the number of apop-
totic bodies in cells expressing GFP fusion proteins (see
Materials and Methods). Using this method, we carried
out preliminary tests 48, 72, and 96 h after transfection in
order to define the suitable time window for assessment
of apoptosis. As compared with nontransfected cells and
cells transfected with empty vector, S1T transfected cells
showed a significant proportion of apoptotic cells 72 h af-
ter transfection, but not before. Both S1T 4-GFP and
S1T 4-GFP significantly induced apoptosis (16.5% for
S1T 4, p-value   0.0001, and 25.5% for S1T 4, p-value  
Figure 7.  Expression of endogenous SERCA2b in cells overex-
pressing S1T (A), relationship between [Ca2 ]er and leakage rate
in control cells, S1T 4-, and S1T 4-expressing cells (B and C),
and dimerization of S1T 4 proteins under mildly denaturing con-
ditions (D). (A) Expression of endogenous SERCA2b is similar in
S1T 4-transfected as compared with nontransfected cells. West-
ern blot analysis of the microsomal fraction of S1T 4 transiently
transfected and nontransfected COS7 cells. The same extracts
were run in parallel (SDS-PAGE). Corresponding membranes
were hybridized with anti-SERCA1 (79B) and anti-SERCA2
(IID8) antibodies. (B) S1T proteins increase ER calcium leakage
from the ER. Dependence on [Ca2 ]er of the Ca2  leak rate from
the ER. Transfection, depletion of Ca2  stores, and aequorin re-
constitution were carried out as described in the legend to Fig. 5;
after the steady state [Ca2 ]er was reached, Ca2  release was initi-
ated by treating the cells with 50  M tBuBHQ. Based on the ex-
perimental trace, the maximum rates of Ca2  release (measured
from the first derivative) at different [Ca2 ]er values were calcu-
lated and plotted for S1T-transfected and control cells. The plot
contains data obtained from independent experiments (n   21
for controls, n   9 for S1T 4, and n   11 for S1T 4). Due to the
mixing time in the luminometer chamber, the kinetics of [Ca2 ]er
decrease are sigmoidal, and the maximum rate is obtained 2–3 s
after the addition of tBuBHQ. Accordingly, we considered the
maximum rates as the best approximation for the initial rate of
[Ca2 ]er reduction. Fitting of the curve was performed using Mi-
crosoft Excel software. (C) [Ca2 ]er measurements performed in
HuH7 cells nontransfected (control) and transfected with the
S1T 4 or S1T 4 construct, having comparable steady state cal-
cium levels. The kinetics of Ca2  efflux is clearly more rapid in
S1T-transfected than in nontransfected cells. (D) S1T 4 proteins
form dimers (92 kD) under mildly denaturing conditions. HuH7
cells were transiently transfected with S1T 4- (right) and
SERCA2b-expressing (left) constructs. Western blots were per-
formed with heated samples treated ( U) or not ( U) with urea.
A 92-kD band corresponding to S1T 4 dimers was detected for
the S1T 4 sample without urea treatment ( U). Note the ab-
sence of a 151-kD band that would have been consistent with het-
erodimers S1T 4–SERCA2b. A 210-kD band corresponding to
SERCA2b dimers was present in the SERCA2b sample without
urea ( U). SR, see legend to Fig. 3.The Journal of Cell Biology, Volume 153, 2001 1310
0.0001) in HuH7 cells, compared with the empty GFP vec-
tor used as control (5.2%). The percentage of apoptotic
cells in SERCA1- and SERCA2-overexpressing cells was
not significantly higher than that seen in control cells (7%,
p   0.029, for SERCA1, and 7%, p   0.09, for SERCA2b)
(Fig. 8 A). Similar results were obtained with CCL13 cells
(data not shown).
Flow cytometry analysis of apoptosis was performed
in HepG2 cells, based on alteration in the mitochon-
drial structure assessed by NAO staining. S1T 4- and
S1T 4-transfected cells showed a significantly higher
number of apoptotic cells, characterized by smaller cell
size associated with a lower incorporation of NAO (22%,
p-value   0.001, and 21%, p-value   0.0019, respectively),
compared with the controls: nontransfected cells (11%)
and pcDNA3-transfected cells (6%) (Fig. 8 B). From these
experiments we conclude that overexpression of S1T pro-
teins induces apoptosis in three different cell lines
(CCL13, HuH7, and HepG2).
Discussion
We describe for the first time that SERCA1 truncated
proteins encoded by new splice variants (S1T) of the
SERCA1 gene. S1T are characterized by exon 4 and/or
exon 11 splicing, leading to COOH-terminally truncated
proteins with deletion of transmembrane segments M2
and/or M5 to M10 including six out of seven trans-
membrane calcium-binding residues (Toyoshima et al.,
2000). Consistent with the analysis of previously reported
SERCA1 mutants (MacLennan et al., 1998), they are un-
able to pump calcium. We show that S1T protein overex-
pression is associated with a reduction in the ER Ca2 
steady state level and an increase in ER Ca2  leakage. Our
results also demonstrate that these proteins modulate
SERCA-dependent ER calcium accumulation and induce
apoptotic cell death.
S1T splice variants were detectable by RT-PCR at vari-
able levels in different adult tissues, including spleen, thy-
mus, pancreas, kidney, and liver, but not in adult and fetal
skeletal muscle and heart. The relative amount of S1T, as
compared with SERCA1 transcripts, differed as a function
of the tissues analyzed, and was higher in fetal liver, kid-
ney, and brain than in the corresponding adult tissues.
These observations were consistent with a switch from
SERCA1 to S1T expression in fetal cells. We detected, by
using Western Blot analysis, the expression of S1T 4 pro-
tein in human nontransfected cell lines T-47D, CCL13,
and Hs27 and confirmed the specificity of these results by
the antigen–antibody competition test. In contrast, S1T
proteins were not detectable in nontransfected HeLa and
LNCaP cell lines. Therefore, S1T proteins were detected
in a primary (Hs27) and two (T-47D and CCL13) out of
four analyzed transformed cells. Together, our results are
consistent with the view that S1T proteins can exert a bio-
logical tightly regulated function.
Using confocal microscopy, S1T were shown to colocal-
ize with SERCA2b into the ER membrane. This localiza-
tion was also predicted by structural analysis of S1T. In-
deed, they retain the NH2-terminal 28 residues previously
identified as being the minimal SERCA1 ER targeting sig-
nal (Guerini et al., 1998), and S1T 4 was also found to
have the first four transmembrane domains (M1 to M4)
that act as the signal anchor and stop transfer sequence
(Bayle et al., 1997). The structure of S1T 4 is unpredict-
able, since this protein also lacks the five COOH-terminal
residues of M1 and the complete M2 transmembrane do-
main. Consequently, it is difficult to clarify the orientation
of the following M3 and M4 in the ER membrane. How-
ever, our results indicate that S1T 4 also localizes to the
ER membrane. This result is supported by previous find-
ings showing that the chimeric protein Xt/St-4, which,
when compared with S1T 4, has the NH2-terminal
Figure 8.  S1T proteins overexpression induce apoptosis. (A)
Morphological assessment of apoptotic bodies in HuH7 cells
transfected with GFP empty vector (GFP), SERCA1–GFP
(SERCA1), and SERCA2-GFP (SERCA2), as controls and in
cells transfected with S1T 4–GFP or S1T 4–GFP fusion con-
structs. Apoptotic bodies were recorded among  600 transfected
cells in at least three independent experiments. NS, not signifi-
cant, *p-value   0.0001 calculated versus GFP-transfected cells.
(B) FACScan® analysis of apoptosis by mitochondrial incorpora-
tion of NAO (ordinates) and cell size (abscisses) in nontrans-
fected HepG2 cells (NTC), cells transfected with S1T 4 and
S1T 4 constructs, and empty vector (pcDNA3). The percentage
of apoptotic cells is defined by lower NAO incorporation associ-
ated with a smaller cell size.Chami et al. SERCA1 Truncated Proteins Reduce ER Calcium 1311
SERCA1 51 residues replaced by 148 viral residues, is tar-
geted to the ER (Chami et al., 2000).
We have shown that the in vitro expression of S1T re-
duces the ER calcium content by 30–50% in three differ-
ent cell lines. We have also shown that this reduction was
induced in a context of ER calcium overload due to
SERCA1 or SERCA2b overexpression. This demon-
strates that S1T expression can modulate SERCA-depen-
dent calcium accumulation. Several mechanisms may be
involved in this effect. Endogenous SERCA2b expression
might be downregulated by the overexpression of S1T. Al-
though we cannot rule out extremely low levels of down-
regulation, our Western blot studies did not evidence such
downregulation, which therefore is unlikely to be a major
mechanism. On the other hand, the rate of Ca2  efflux in
S1T-overexpressing cells was clearly faster than in control
cells and thus S1T expression increases the Ca2  leakage
from the ER. A possible explanation is that S1T proteins
bind the endogenous SERCA2b and partially block its
pumping activity. This direct interaction is possible since
SERCA proteins have been shown to form aggregates
(Martonosi, 1996). However, Western blot analyses of S1T
transiently transfected cells, performed in mild denaturing
conditions (heated samples without urea), failed to dem-
onstrate heterodimers of S1T with endogenous SERCA2b
proteins. In contrast, homodimers of S1T were easily and
clearly detected, at higher proportions than SERCA2b ho-
modimers. Actually, the truncation of S1T allows several
residues of M2, M3, and M4, interacting with M5 and M6
residues in SERCA1a (see Figure 3 a in Toyoshima et al.,
2000), to be in contact with the ER membrane lipids, and
therefore in a thermodynamic unfavorable state. This is
particularly critical for the C O and NH of residues Ile-
307 to Gly-310 in M4, which are unwound (i.e., non–  heli-
cal), and predictably not H-bonded when they are in con-
tact with the lipid hydrophobic region. In this setting, S1T
homodimers, allowing these residues to be H bonded, ap-
pear as a more stable conformation. Thus, although it is
difficult to completely exclude the possibility of a direct
S1T–SERCA2b interaction blocking the endogenous ATP-
ase, it is clear that S1T homodimers are more stable than
heterodimers in HuH7-transfected cells and that their pre-
sence, in native conditions, is plausible.
Taking into account the fact that M4 is still present in
S1T proteins and contains four of the six calcium-binding
residues of calcium-binding site II (Fig. 1 B), it is reason-
able to hypothesize that S1T homodimers may form a cat-
ion channel. Due to the structural modifications of the
truncated proteins in respect to SERCA1, it is also possi-
ble that such a channel may involve negatively charged
residues that could contribute to the increase of ER Ca2 
leakage. Glu-58 in M1 and Gln-108 in M2 (Fig. 1 D), which
are located close to Glu-309, are good candidates to play
this role.
We demonstrated that S1T overexpression induces
apoptosis in three different cell lines, as determined by the
counting of apoptotic bodies and by FACS® analysis of the
mitochondrial structure using NAO incorporation. Several
reports have shown that SERCA inhibition by different
compounds and mechanisms (thapsigargin, tBuBHQ, and
cyclopiazonic acid) is followed by apoptosis (Furuya et al.,
1994; Zhu and Loh, 1995; Preston et al., 1997; Zhou et al.,
1998; Wertz and Dixit, 2000). In these models, SERCA in-
hibition induced [Ca2 ]er depletion associated with capaci-
tative calcium entry and an increase in cytosolic free cal-
cium concentration ([Ca2 ]c). In certain experimental
systems, the perturbation of calcium homeostasis in both
cell compartments has been associated with apoptotic cell
death (Bian et al., 1997; Skryma et al., 2000). Other re-
ports have shown, however, that ER depletion alone was
sufficient to induce apoptosis (Furuya et al., 1994; He et
al., 1997; Zhou et al., 1998; Wertz and Dixit, 2000). ER cal-
cium depletion induced by the overexpression of S1T was
found in HuH7 cells 48 and 72 h after transfection,
whereas a significant number of apoptotic bodies was de-
tected in the same cells 72 h, but not 48 h, after transfec-
tion. In this context, S1T-induced ER calcium depletion
might play a role in apoptosis of transfected cells, although
we cannot rule out that S1T may lead to apoptosis by
means of a mechanism that differs from a reduction in the
ER calcium pool. In fact, a reduction in the ER calcium
content has been described in HeLa (Pinton et al., 2000)
and HEK (Foyouzi-Youssefi et al., 2000) cells overex-
pressing the antiapoptotic protein Bcl2. Furthermore, ER
calcium depletion in lymphoid cells has been associated
with a delay in glucocorticoid-induced apoptosis (Distel-
horst and McCormick, 1996). Differences in experimental
conditions, cell type, and the degree of ER calcium reduc-
tion may explain the contrasting results reported concern-
ing the relationship between reduced ER calcium pool,
apoptosis, and expression of antiapoptotic proteins.
SERCA proteins are critical regulatory components of
Ca2  signaling. On the one hand, by transporting cytosolic
Ca2  against a concentration gradient into the lumen of the
ER, they represent a relevant factor that controls Ca2  sig-
nals in the cytosol (Berridge et al., 1998). It has been
shown that SERCA genes control the IP3-mediated cal-
cium waves (Camacho and Lechleiter, 1993), the ampli-
tude and duration of which differentially activate certain
transcription factors (Dolmetsch et al., 1997). On the other
hand, SERCA proteins also control the free calcium level
in the ER, which is involved in basic cellular processes
such as protein synthesis, folding, and stress response
(Meldolesi and Pozzan, 1998). In this setting, it is conceiv-
able that the whole process of Ca2  accumulation into and
release from the ER has to be finely tuned. Indeed,
SERCA2a and SERCA1 pump activities have been shown
to be modulated, in muscle cells, by phospholamban,
which undergoes a physical interaction with SERCA trans-
membrane domain M6 (Asahi et al., 2000). In fast-twitch
skeletal muscle cells, sarcolipin interacts with SERCA1
and inhibits Ca2  uptake in a Ca2 -dependent manner
(Odermatt et al., 1998). SERCA2b may also be inhibited
by a physical interaction with phosphorylated calnexin, a
transmembrane ER chaperone. It has been shown that
IP3-induced Ca2  release results in calnexin dephosphory-
lation and SERCA derepression (Roderick et al., 2000).
Our results now provide evidence for a further mechanism
modulating ER Ca2  loading in nonmuscle cells.
In conclusion, our work describes new truncated
SERCA1 proteins, which are unable to pump calcium and
display a dominant negative biological effect on SERCA-
dependent ER calcium accumulation. It reveals a previ-
ously unknown mechanism involved in ER calcium ho-The Journal of Cell Biology, Volume 153, 2001 1312
meostasis and may constitute a new tool to study the phys-
iological role of SERCA proteins in calcium signaling and
control of cell death.
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